OncoSec Medical Company Profile (NASDAQ:ONCS)

Analyst Ratings

Consensus Ratings for OncoSec Medical (NASDAQ:ONCS) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.33 (412.82% upside)

Analysts' Ratings History for OncoSec Medical (NASDAQ:ONCS)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2016Maxim GroupDowngradeBuy$17.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2016Rodman & RenshawInitiated CoverageBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for OncoSec Medical (NASDAQ:ONCS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/12/2016        
6/9/2016Q316($0.43)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q216($0.46)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/8/2015Q116($0.48)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/14/2015Q415($0.40)($0.48)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015($0.02)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/8/2014($0.02)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/13/2014($0.01)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/16/2014($0.01)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OncoSec Medical (NASDAQ:ONCS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.43)($0.43)($0.43)
Q2 20161($0.44)($0.44)($0.44)
Q3 20161($0.45)($0.45)($0.45)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OncoSec Medical (NASDAQ:ONCS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OncoSec Medical (NASDAQ:ONCS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
10/16/2015Punit DhillonCEOBuy10,000$4.25$42,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Punit DhillonCEOBuy2,500$6.74$16,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Anthony E Maida IIIDirectorBuy22,800$0.81$18,468.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2014Punit DhillonCEOBuy50,000$0.80$40,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OncoSec Medical (NASDAQ:ONCS)
DateHeadline
07/24/16 05:08 PMOncosec (NASDAQ:ONCS) price target reduced to $5 as covered today by Maxim Group - Breaking Finance News
07/22/16 05:31 PMInvestor Update: Earnings and Target Price Recap on OncoSec Medical Inc (NASDAQ:ONCS) - Press Telegraph
07/22/16 05:31 PMRodman & Renshaw Sees 243% Upside In OncoSec Medical Shares - Benzinga
07/22/16 05:31 PMChecking in on Stock Volatility for: OncoSec Medical Incorporated (NASDAQ:ONCS) - Engelwood Daily
07/21/16 08:32 AMOncoSec Medical Inc (NASDAQ:ONCS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/19/16 07:01 AMOncoSec Medical Inc (NASDAQ:ONCS) Wall Street Analyst Recommendation Outlook - TGP
07/15/16 04:41 PMWhat's Ahead for OncoSec Medical Inc After Forming Multiple Bottom Chart Pattern? - Consumer Eagle
07/11/16 05:38 PMWall Street Ratings and Target Price Views on OncoSec Medical Inc (NASDAQ:ONCS) - Telanagana Press
07/08/16 08:35 AMCan OncoSec Medical Inc (NASDAQ:ONCS) Improve on the Earnings Front? - Engelwood Daily
07/02/16 08:25 AMOncosec Medical (NASDAQ:ONCS) Short Interest Decreased By 16.03% - Engelwood Daily
07/01/16 04:01 PMONCOSEC MEDICAL INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and Exhi -
06/29/16 05:33 PMWatching Stock Volatility for: OncoSec Medical Incorporated (NASDAQ:ONCS) - Engelwood Daily
06/28/16 10:30 AMOncosec Medical (NASDAQ:ONCS) Short Interest Decreased By 16.03% - Press Telegraph
06/28/16 10:30 AMCovering the Bases on OncoSec Medical Inc (NASDAQ:ONCS): Where is the Stock Going? - Press Telegraph
06/28/16 08:41 AMOncoSec Presents Significant Advancements in Electroporation Technology for Immunotherapy - [at noodls] - SAN DIEGO, June 28, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, presented recent advancements in electroporation ...
06/18/16 09:51 AMRevenue Update on OncoSec Medical Inc(NASDAQ:ONCS) - TheFounders Daily
06/18/16 09:51 AMCompany Update (NASDAQ:ONCS): OncoSec Medical Inc Presents Preliminary Findings from Head and Neck Phase II ... - Smarter Analyst
06/16/16 05:52 PMBiotechs Setup To Bounce Once Again
06/16/16 09:39 AMOncoSec Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference - [at noodls] - SAN DIEGO, June 16, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented preliminary findings ...
06/09/16 03:19 PMOncoSec Announces Third Quarter and YTD Results for Fiscal Year 2016 - [at noodls] - SAN DIEGO, June 9, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced key corporate objectives ...
06/08/16 06:01 PMColony Capital, Inc. (NYSE:CLNY) Rose 2.96%: OncoSec Medical Incorporated (NASDAQ:ONCS), PetMed Express ... - KC Register
06/06/16 05:34 PMOncosec Medical (ONCS) Shows Utility of T-cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapies - StreetInsider.com
06/06/16 09:21 AMOncoSec Medical : Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy
06/06/16 05:28 AMOncoSec Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy - [at noodls] - SAN DIEGO, June 6, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that its collaborators ...
06/03/16 06:08 PMOncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences Report - Yahoo Finance UK
06/03/16 08:31 AMStock Review and Earnings Check on OncoSec Medical Inc (NASDAQ:ONCS) - HNN - Stock Review and Earnings Check on OncoSec Medical Inc (NASDAQ:ONCS)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting OncoSec Medical Inc (NASDAQ:ONCS) to report quarterly EPS of $-0.43. The company's next earnings report is expected to be published on ...and more »
06/02/16 06:01 PMBroker Watchlist: OncoSec Medical (ONCS) - Share Trading News - Broker Watchlist: OncoSec Medical (ONCS)Share Trading NewsOncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.OncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences ReportMarketwired (press release)all 5 news articles »
06/02/16 09:57 AMOncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences Report - [Marketwired] - Cancer patients often receive multiple rounds of chemotherapy, with new drugs incorporated into treatment programs as tumors develop resistance. OncoSec Medical Incorporated's Punit Dhillon describes ...
06/02/16 08:36 AMOncoSec Medical Inc's Stock Formed A Several Months Bearish Multiple Bottom - HNN - OncoSec Medical Inc's Stock Formed A Several Months Bearish Multiple BottomHNNThe stock of OncoSec Medical Inc (ONCS) shows a multiple bottoms pattern with $1.60 target or 13.00% below today's $1.84 share price. The 8 months chart pattern indicates high risk for the $33.02 million company. It was reported on Jun, 2 by Finviz.com.
06/01/16 05:23 AMOncoSec to Present at Scientific and Investment Conferences in June - [at noodls] - SAN DIEGO, June 1, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its ...
05/31/16 09:30 AMShare Rating Focus on OncoSec Medical Inc (NASDAQ:ONCS) - HNN - Share Rating Focus on OncoSec Medical Inc (NASDAQ:ONCS)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 1 on shares of OncoSec Medical Inc (NASDAQ:ONCS). Covering analysts will ...and more »
05/28/16 02:24 AMStock Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $10 Million At-The-Market Registered Direct Offering - Smarter Analyst - Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $10 Million At-The-Market Registered Direct OfferingSmarter AnalystOncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it has closed its previously announced at-the-market registered direct offering with a single healthcare dedicated ...and more »
05/26/16 07:37 PMOncoSec Closes $10 Million At-The-Market Registered Direct Offering - [at noodls] - SAN DIEGO, May 26, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it has closed its ...
05/24/16 04:22 PMONCOSEC MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur -
05/22/16 12:20 PMFriday's Mid-Day Movers: Linn Energy (LINE), Breitburn Energy Partners (BBEP), OncoSec Medical Inc (ONCS ... - Analyst Ratings - Friday's Mid-Day Movers: Linn Energy (LINE), Breitburn Energy Partners (BBEP), OncoSec Medical Inc (ONCS ...Analyst RatingsSo far Friday, May 20, NASDAQ is up 1.48% and the S&P is up 0.84%. Let's take a look at this mornings' most active stocks and the relevant expert activity. Linn Energy (NASDAQ:LINE), Breitburn Energy Partners (NASDAQ:BBEP), OncoSec Medical Inc ...and more »
05/18/16 09:26 PMOncoSec to Host Third Quarter Financial Results Conference Call on June 9, 2016 - PR Newswire (press release) - OncoSec to Host Third Quarter Financial Results Conference Call on June 9, 2016PR Newswire (press release)SAN DIEGO, May 18, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company will host its fiscal third quarter 2016 ...and more »
05/17/16 07:21 PMMorning Watch List: Prologis, Inc. (NYSE:PLD), OncoSec Medical Incorporated (NASDAQ:ONCS), MannKind Corp ... - KC Register - Morning Watch List: Prologis, Inc. (NYSE:PLD), OncoSec Medical Incorporated (NASDAQ:ONCS), MannKind Corp ...KC RegisterPrologis, Inc. (NYSE:PLD) is 0.61% away from its 52 week high and its 52 week range is $35.25 – 48.18. OncoSec Medical Incorporated (NASDAQ:ONCS)'s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a note issued to ...and more »
05/11/16 10:00 PMOncosec Medical (NASDAQ:ONCS) Short Interest Increased By 14.56% - B.O.D.Y Confidential - Oncosec Medical (NASDAQ:ONCS) Short Interest Increased By 14.56%B.O.D.Y ConfidentialThe short interest to Oncosec Medical's float is 2.12%. The stock increased 0.60% or $0.01 on May 11, hitting $1.67. About 53,896 shares traded hands. OncoSec Medical Inc (NASDAQ:ONCS) has declined 60.66% since October 5, 2015 and is downtrending.
05/05/16 10:07 PMEarnings Outlook on OncoSec Medical Inc (NASDAQ:ONCS) - B.O.D.Y Confidential - Earnings Outlook on OncoSec Medical Inc (NASDAQ:ONCS)B.O.D.Y ConfidentialAnalysts and investors will be anticipating OncoSec Medical Inc (NASDAQ:ONCS)'s next earnings release which is expected to be posted on or around 2016-06-14. Sell-side research firms on Wall Street are expecting that the company will post EPS of $-0.43 ...and more »
05/03/16 12:27 AMOncosec Medical (NASDAQ:ONCS) Shorted Shares Increased By 14.56% - B.O.D.Y Confidential - Oncosec Medical (NASDAQ:ONCS) Shorted Shares Increased By 14.56%B.O.D.Y ConfidentialThe short interest to Oncosec Medical's float is 2.12%. The stock is down 4.59% or $0.09 after the news, hitting $1.87 per share. About 75,850 shares traded hands. OncoSec Medical Inc (NASDAQ:ONCS) has declined 71.01% since September 24, 2015 and ...Broker Outlook For The Week Ahead: OncoSec Medical (ONCS)Share Trading Newsall 2 news articles »
05/03/16 12:27 AMShining on Major News: OncoSec Medical Incorporated (NASDAQ:ONCS), Chimera Investment Corporation (NYSE ... - KC Register - Shining on Major News: OncoSec Medical Incorporated (NASDAQ:ONCS), Chimera Investment Corporation (NYSE ...KC RegisterOn 19 April, OncoSec Medical Incorporated (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, presented long-term, follow-up data of patients who were treated with its investigational therapy ImmunoPulse™ IL-12 ...and more »
04/27/16 09:59 PMOncoSec Medical Inc (NASDAQ:ONCS) Wall Street Rating in Focus - News Tribune - OncoSec Medical Inc (NASDAQ:ONCS) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 4 equity research firms that cover shares of OncoSec Medical Inc (NASDAQ:ONCS).and more »
04/26/16 08:24 PMOncoSec Medical Inc (NASDAQ:ONCS) Share Rating Recap - B.O.D.Y Confidential - OncoSec Medical Inc (NASDAQ:ONCS) Share Rating RecapB.O.D.Y ConfidentialShares of OncoSec Medical Inc (NASDAQ:ONCS) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...
04/26/16 05:12 AMIs OncoSec Medical Inc a Sell? The Stock Declines Again - The Post - Is OncoSec Medical Inc a Sell? The Stock Declines AgainThe PostThe stock of OncoSec Medical Inc (NASDAQ:ONCS) is a huge mover today! The stock is down 7.46% or $0.18 after the news, hitting $2.22 per share. About 347,506 shares traded hands. OncoSec Medical Inc (NASDAQ:ONCS) has declined 61.97% since ...OncoSec Medical (ONCS) Updated Analyst CoverageRisers & Fallersall 2 news articles »
04/26/16 05:12 AMStock Shooting Lower Today: OncoSec Medical Incorporated (NASDAQ:ONCS) - The Post - Stock Shooting Lower Today: OncoSec Medical Incorporated (NASDAQ:ONCS)The PostOncoSec Medical Incorporated (NASDAQ:ONCS) was a top loser in today's session as the company saw shares drop -8.67% on the day at the time of writing. Stocks whose market prices drop the most during the trading day are bluntly referred to as losers.and more »
04/22/16 05:25 AMHot stocks Update: Repros Therapeutics Inc. (NASDAQ:RPRX) , OncoSec Medical Incorporated (NASDAQ:ONCS) - Is stories - Is storiesHot stocks Update: Repros Therapeutics Inc. (NASDAQ:RPRX) , OncoSec Medical Incorporated (NASDAQ:ONCS)Is storiesRepros Therapeutics Inc. (NASDAQ:RPRX) decreased -8.63% to $2.86 while traded 5.04 million shares on 4/20/2016. The stock price negotiated for value between $2.80 to $3.04 in recent trading session. During the past 52 weeks, the stock's price witnessed ...and more »
11/19/15 05:14 AMOncoSec to Host First Quarter Financial Results Conference Call on December 8, 2015 - [at noodls] - SAN DIEGO, Nov. 19, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company will ...
11/09/15 03:26 PMOncoSec Medical Closes $7.5 Million Registered Direct Offering - [at noodls] - SAN DIEGO, Nov. 9, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company has ...
11/03/15 07:17 PMOncoSec Announces $7.5 Million Registered Direct Offering - [at noodls] - SAN DIEGO, Nov. 3, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered ...
10/29/15 05:28 AMOncoSec Enrolls First Patient in Biomarker-Focused Pilot Study in Triple Negative Breast Cancer - [at noodls] - SAN DIEGO, Oct. 29, 2015 /PRNewswire/ -- OncoSec Medical Incorporated ('OncoSec') (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that the Company has ...

Social

About OncoSec Medical

OncoSec Medical logoOncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. The Company's portfolio includes biologic immunology therapeutic product candidates intended to treat a range of tumor types. The Company's technology includes property relating to its ImmunoPulse delivery technology. The Company's ImmunoPulse is an electroporation delivery device that the Company uses in combination with its therapeutic product candidates, including deoxyribonucleic acid (DNA) plasmids that encode for immunologically active agents, to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer. Its electroporation devices consist of an electrical pulse generator and disposable applicators. The Company's ImmunoPulse product candidates are based on its DNA based immunotherapy technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ONCS
  • CUSIP:
Key Metrics:
  • Previous Close: $1.82
  • 50 Day Moving Average: $1.68
  • 200 Day Moving Average: $1.88
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $32.10M
  • Beta: 2.22
  • Current Year EPS Consensus Estimate: $-1.61 EPS
  • Next Year EPS Consensus Estimate: $-1.42 EPS
Additional Links:
OncoSec Medical (NASDAQ:ONCS) Chart for Saturday, July, 30, 2016